Conference item : Abstract

Gene therapy for surfactant protein B deficiency using recombinant AAV

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Meyer-Berg, H., Hyde, S., & Gill, D. (2019). Gene therapy for surfactant protein B deficiency using recombinant AAV. 22nd American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2019), 27(4-S1), 250.

MLA Style

Meyer-Berg, H, et al. “Gene Therapy for Surfactant Protein B Deficiency Using Recombinant AAV.” 22nd American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2019), vol. 27, nos. 4-S1, 2019, p. 250.

Chicago Style

Meyer-Berg, H, S Hyde, and D Gill. 2019. “Gene Therapy for Surfactant Protein B Deficiency Using Recombinant AAV.” In 22nd American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2019), 27:250. Elsevier.
Print

Access Document

Files:: Meyer-Berg_et_al_Gene_therapy.pdf

(Preview, Accepted manuscript, pdf, 96.4KB, Terms of use)

Publisher copy:: 10.1016/j.ymthe.2019.04.004

Authors

+ Meyer-Berg, H More by this author

Role:: Author

+ Hyde, S More by this author

Role:: Author

+ Gill, D More by this author

Institution:: University of Oxford
Division:: MSD
Department:: RDM
Sub department:: RDM Clinical Laboratory Sciences
Oxford college:: University College
Role:: Author
ORCID:: 0000-0002-5264-054X

Publisher:: Elsevier
Journal:: Molecular Therapy More from this journal
Volume:: 27
Issue:: 4-S1
Pages:: 250
Publication date:: 2019-04-12
Acceptance date:: 2019-03-20
Event title:: 22nd American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2019)
Event location:: Washington D.C., USA
Event start date:: 2019-04-29
Event end date:: 2019-05-02
DOI:: 10.1016/j.ymthe.2019.04.004
EISSN:: 1525-0024
ISSN:: 1525-0016

Keywords:: FFR
Subtype:: Abstract
Pubs id:: pubs:1015815
UUID:: uuid:3bb8c6ae-4fe1-4c0c-abf5-fbb8582b74af
Local pid:: pubs:1015815
Source identifiers:: 1015815
Deposit date:: 2019-06-18
ARK identifier:: ark:/29072/ora_3bb8c6ae4fe14c0cabf5fbb8582b74af

Terms of use

Copyright holder:: Meyer-Berg et al.
Copyright date:: 2019
Rights statement:: © 2019 The Author(s).
Notes:: This item is the abstract for a paper presented at the 22nd American Society of Gene and Cell Therapy Annual Meeting (ASGCT 2019), Washington DC, USA, April-May 2019. This is the accepted manuscript version of the abstract, available under a Creative Commons, Attribution, Non-Commercial, No-Derivatives licence. The final version is available online from Elsevier at: https://doi.org/10.1016/j.ymthe.2019.04.004

Licence:: CC Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP